Browse our anti-S100A9 (S100A9) Antibodies

Full name:
anti-S100 Calcium Binding Protein A9 Antibodies (S100A9)
On www.antibodies-online.com are 255 S100 Calcium Binding Protein A9 (S100A9) Antibodies from 23 different suppliers available. Additionally we are shipping S100A9 Kits (66) and S100A9 Proteins (33) and many more products for this protein. A total of 361 S100A9 products are currently listed.
Synonyms:
60B8Ag, AW546964, BEE22, Cagb, CFAG, CGLB, GAGB, L1Ag, LIAG, MAC387, MIF, MRP-14, Mrp14, NIF, p14, S100A9
list all antibodies Gene Name GeneID UniProt
S100A9 6280 P06702
S100A9 94195 P50116
S100A9 20202 P31725

Show all species

Show all synonyms

Most Popular Reactivities for anti-S100A9 (S100A9) Antibodies

Select your species and application

anti-Human S100A9 Antibodies:

anti-Rat (Rattus) S100A9 Antibodies:

anti-Mouse (Murine) S100A9 Antibodies:

All available anti-S100A9 Antibodies

Go to our pre-filtered search.

Top referenced anti-S100A9 Antibodies

  1. Human Monoclonal S100A9 Primary Antibody for EIA, FACS - ABIN111889 : Brandtzaeg, Jones, Flavell, Fagerhol: Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen. in Journal of clinical pathology 1989 (PubMed)
    Show all 11 references for 111889

  2. Human Monoclonal S100A9 Primary Antibody for EIA, FACS - ABIN111888 : Delabie, de Wolf-Peeters, van den Oord, Desmet: Differential expression of the calcium-binding proteins MRP8 and MRP14 in granulomatous conditions: an immunohistochemical study. in Clinical and experimental immunology 1990 (PubMed)
    Show all 9 references for 111888

  3. Cow (Bovine) Monoclonal S100A9 Primary Antibody for EIA, FACS - ABIN111887 : Mues, Brisse, Zwadlo, Themann, Bender, Sorg: Phenotyping of macrophages with monoclonal antibodies in endomyocardial biopsies as a new approach to diagnosis of myocarditis. in European heart journal 1990 (PubMed)
    Show all 8 references for 111887

  4. Human Monoclonal S100A9 Primary Antibody for EIA, FACS - ABIN111886 : Odink, Cerletti, Brüggen, Clerc, Tarcsay, Zwadlo, Gerhards, Schlegel, Sorg: Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. in Nature 1987 (PubMed)
    Show all 8 references for 111886

  5. Human Monoclonal S100A9 Primary Antibody for IHC (fro), FACS - ABIN954657 : Klein, Pino, Johnson, Davies, Nagpal, Thacher, Krasinski, Chandraratna: Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists. in The Journal of biological chemistry 1996 (PubMed)
    Show all 3 references for 954657

  6. Human Monoclonal S100A9 Primary Antibody for IHC (fro), FACS - ABIN954656 : Nagpal, Thacher, Patel, Friant, Malhotra, Shafer, Krasinski, Asano, Teng, Duvic, Chandraratna: Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis. in Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997 (PubMed)
    Show all 3 references for 954656

  7. Human Monoclonal S100A9 Primary Antibody for IHC (fro), FACS - ABIN954655 : Thacher, Nagpal, Klein, Arefieg, Krasinski, DiSepio, Agarwal, Johnson, Eckert, Chandraratna: Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes. in Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999 (PubMed)
    Show all 3 references for 954655

  8. Human Polyclonal S100A9 Primary Antibody for IHC, WB - ABIN2786758 : Ghavami, Kerkhoff, Chazin, Kadkhoda, Xiao, Zuse, Hashemi, Eshraghi, Schulze-Osthoff, Klonisch, Los: S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. in Biochimica et biophysica acta 2008 (PubMed)

More Antibodies against S100A9 Interaction Partners

Human S100 Calcium Binding Protein A9 (S100A9) interaction partners

  1. Data indicate a statistical correlation between fecal calprotectin (show S100A8 Antibodies) (FC) and gastrointestinal graft-versus-host disease (GvHD).

  2. Perinatal alarmins S100A8 (show S100A8 Antibodies) and S100A9 specifically altered MyD88 (show MYD88 Antibodies)-dependent proinflammatory gene programs. S100 programming prevented hyperinflammatory responses without impairing pathogen defense. TRIF (show TRIM69 Antibodies)-adaptor-dependent regulatory genes remained unaffected by perinatal S100 programming and responded strongly to lipopolysaccharide, but were barely expressed.

  3. These results suggest a preponderant role for the protein S100-A9 as an activator of the NF-kappa B (show NFKB1 Antibodies) pathway during Chronic lymphocytic leukemia progression and suggest that the leukemic clone can generate an autoactivation loop through S100-A9 expression, NF-kappa B (show NFKB1 Antibodies) activation, and exosome secretion.

  4. Expression of S100A8 (show S100A8 Antibodies), S100A9 and S100A12 (show S100A12 Antibodies) is modulated by eicosapentaenoic acid and docosahexaenoic acid during Inflammation in adipose tissue and mononuclear cells.

  5. Fecal calprotectin (show S100A8 Antibodies) levels were increased in pediatric subjects who showed signs of severe Clostridium difficile infection (CDI). Increased serum calprotectin (show S100A8 Antibodies) levels were associated with increased disease severity in 48 adults with CDI

  6. High S100A9 expression is associated with lung metastasis in malignant melanoma.

  7. Data show that the standardized nerve growth factor (NGF) concentration was negatively correlated with continuous pain, neuropathic pain and total score, and the standardized S100 proteins S100A8 (show S100A8 Antibodies)/A9 concentration was positively correlated with present pain intensity and continuous pain.

  8. A significant positive correlation was found between the serum calprotectin (show S100A8 Antibodies) and insulin (show INS Antibodies) resistance in polycystic ovary syndrome patients.

  9. these results indicate that CD14 (show NDUFA2 Antibodies) is a co-receptor of TLR4 (show TLR4 Antibodies) in the S100A9-induced cytokine response.

  10. S100A8 (show S100A8 Antibodies) and S100A9 proteins in concentrations secreted by CD34 (show CD34 Antibodies)(-)/CD31 (show HBA1 Antibodies)(+) circulating angiogenic cells (CACs) with impaired function reduce endothelial cell capillary-like network formation. These effects appear to be mediated by Toll-like receptor 4 (show TLR4 Antibodies) and are absent with S100A8 (show S100A8 Antibodies) and S100A9 in concentrations secreted by healthy CD34 (show CD34 Antibodies)(-)/CD31 (show HBA1 Antibodies)(+) CACs.

Rabbit S100 Calcium Binding Protein A9 (S100A9) interaction partners

  1. this study shows that S100A9 inhibits B lymphopoiesis by acting on myeloid cells and promoting the release of inflammatory molecules, including IL-1beta (show IL1B Antibodies)

Pig (Porcine) S100 Calcium Binding Protein A9 (S100A9) interaction partners

  1. Study verified porcine calprotectin (S100A8 (show S100A8 Antibodies)/A9) expression at the protein level in multiple Haemophilus parasuis infected tissues and explored their molecular characterization.

Cow (Bovine) S100 Calcium Binding Protein A9 (S100A9) interaction partners

  1. Data suggest that up-regulation of S100A8 (show S100A8 Antibodies) and S100A9 is a key component of early endometrial response to uterine involution in the post-partum period and to prevent chronic endometritis/uterine inflammation; up-regulation can be influenced by diet.

Mouse (Murine) S100 Calcium Binding Protein A9 (S100A9) interaction partners

  1. Perinatal alarmins S100A8 (show S100A8 Antibodies) and S100A9 specifically altered MyD88 (show MYD88 Antibodies)-dependent proinflammatory gene programs. S100 programming prevented hyperinflammatory responses without impairing pathogen defense. TRIF (show RNF138 Antibodies)-adaptor-dependent regulatory genes remained unaffected by perinatal S100 programming and responded strongly to lipopolysaccharide, but were barely expressed.

  2. vitro studies on the mechanisms/pathways involved in leukemic cell differentiation revealed that binding of S100A9 to Toll-like receptor 4 (TLR4 (show TLR4 Antibodies)) promotes activation of p38 mitogen-activated protein kinase (show MAPK14 Antibodies), extracellular signal-regulated kinases 1 and 2, and Jun N-terminal kinase (show MAPK8 Antibodies) signaling pathways, leading to myelomonocytic and monocytic AML (show RUNX1 Antibodies) cell differentiation.

  3. these results indicate that CD14 (show CD14 Antibodies) is a co-receptor of TLR4 (show TLR4 Antibodies) in the S100A9-induced cytokine response.

  4. Mechanistic studies showed that in MDSCs, ATF3 (show ATF3 Antibodies) was transrepressed by the GC receptor GR through direct binding to the negative GR-response element. S100A9 is the major transcriptional target of ATF3 (show ATF3 Antibodies) in Granulocytic Myeloid-derived Suppressor Cells.

  5. CHI3L1 (show CHI3L1 Antibodies)-mediated cell proliferation/survival involves partial downregulation of the pro-apoptotic S100A9 protein that is highly expressed during the acute phase of colitis, by binding to the S100A9 receptor, RAGE (show AGER Antibodies) (Receptor for Advanced Glycation End products).

  6. Although MRP-8 (show S100A8 Antibodies)/-14 expression is highly increased in experimental, these proteins do not contribute to the pathogenesis in the effector phase of epidermolysis bullosa acquisita and bullous pemphigoid (show DST Antibodies).

  7. Rps14 (show RPS14 Antibodies) haploinsufficiency in del(5q) myelodysplastic syndrome is linked to activation of the innate immune system and induction of S100A8 (show S100A8 Antibodies)-S100A9 expression, leading to a p53 (show TP53 Antibodies)-dependent erythroid differentiation defect.

  8. MRP8 (show S100A8 Antibodies)/14 serves in an unexpected protective role for the lung in staphylococcal pneumonia.

  9. Canonical Wnt (show WNT2 Antibodies) signaling was decreased after induction of experimental OA in S100A9-deficient mice.

  10. Alarmins S100A8 (show S100A8 Antibodies)/S100A9 aggravate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human symptomatic osteoarthritis.

S100A9 Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in the inhibition of casein kinase and altered expression of this protein is associated with the disease cystic fibrosis.

Alternative names and synonyms associated with S100A9

  • S100 calcium binding protein A9 (S100A9) antibody
  • S100 calcium binding protein A9 (S100a9) antibody
  • S100 calcium binding protein A9 (calgranulin B) (S100a9) antibody
  • 60B8Ag antibody
  • AW546964 antibody
  • BEE22 antibody
  • Cagb antibody
  • CFAG antibody
  • CGLB antibody
  • GAGB antibody
  • L1Ag antibody
  • LIAG antibody
  • MAC387 antibody
  • MIF antibody
  • MRP-14 antibody
  • Mrp14 antibody
  • NIF antibody
  • p14 antibody
  • S100A9 antibody

Protein level used designations for S100A9

S100 calcium binding protein A9 , MRP-14 , S100 calcium-binding protein A9 (calgranulin B) , calgranulin B , calgranulin-B , calprotectin L1H subunit , leukocyte L1 complex heavy chain , migration inhibitory factor-related protein 14 , protein S100-A9 , S100 calcium binding protein A9 (calgranulin B) , intracellular calcium-binding protein (MRP14) , myeloid-related protein 14 , p14 , S100 calcium-binding protein A9 , RNA-binding region containing protein 2-like , calprotectin , BEE22 , neutrophil cytosolic 23 kDa protein , p23 , protein MRP-126

GENE ID SPECIES
457998 Pan troglodytes
714690 Macaca mulatta
100294530 Equus caballus
6280 Homo sapiens
94195 Rattus norvegicus
100008704 Oryctolagus cuniculus
100735238 Cavia porcellus
100127489 Sus scrofa
532569 Bos taurus
490463 Canis lupus familiaris
426356 Gallus gallus
20202 Mus musculus
Selected quality suppliers for anti-S100A9 (S100A9) Antibodies
Did you look for something else?